GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Debt-to-Asset

DuChemBio Co (XKRX:176750) Debt-to-Asset : 0.44 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Debt-to-Asset?

DuChemBio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩14,726 Mil. DuChemBio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩7,030 Mil. DuChemBio Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was ₩49,277 Mil. DuChemBio Co's debt to asset for the quarter that ended in Dec. 2023 was 0.44.


DuChemBio Co Debt-to-Asset Historical Data

The historical data trend for DuChemBio Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Debt-to-Asset Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.83 1.08 0.54 0.53 0.44

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset Get a 7-Day Free Trial 0.83 1.08 0.54 0.53 0.44

Competitive Comparison of DuChemBio Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuChemBio Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Debt-to-Asset falls into.



DuChemBio Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DuChemBio Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(14725.659 + 7029.692) / 49276.827
=0.44

DuChemBio Co's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(14725.659 + 7029.692) / 49276.827
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DuChemBio Co  (XKRX:176750) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


DuChemBio Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines